Head-to-head
CoreAge Rx vs LIV by WellNow
CoreAge Rx and LIV by WellNow both offer GLP-1 telehealth, but they make different trade-offs on speed to first dose, flat pricing, access and molecule choice. Here they are side-by-side on the Rx-Readiness Score — our readiness rubric.
CoreAge Rx
Higher scoreRanked #1 · Grade A
Best for: Working moms who want a decision, not a research project — flat pricing, both semaglutide and tirzepatide, and no scheduled video visit to book around work and pickup.
Visit CoreAge RxLIV by WellNow
Ranked #125 · Grade C
Best for: Working moms in IL, IN, MI, NY or PA who want a flat, all-inclusive compounded-semaglutide price backed by a recognizable urgent-care brand, and don't need tirzepatide or insurance billing.
Visit LIV by WellNowThe verdict
CoreAge Rx edges out LIV by WellNow on the Rx-Readiness Score, 95 to 52 (A vs C). Working moms who want a decision, not a research project — flat pricing, both semaglutide and tirzepatide, and no scheduled video visit to book around work and pickup.
LIV by WellNow is still a genuine option — the telehealth weight-management arm of WellNow Urgent Care — a flat $279/mo covers compounded semaglutide, supplies and unlimited virtual visits with no hidden fees, standard 18-plus/BMI-30 (or 27-with-comorbidity) eligibility, and the site honestly discloses the medication isn't FDA-approved, but it's semaglutide-only in just five states (IL, IN, MI, NY, PA) with no insurance accepted. Weigh the six readiness factors below against your own priorities.
Side-by-side on the six factors
Both providers scored on the same readiness rubric — the higher side on each factor is marked. See the methodology.
Price, access & features
| Detail | CoreAge Rx | LIV by WellNow |
|---|---|---|
| Rx-Readiness Score | 95/100 · A | 52/100 · C |
| Overall rank | #1 | #125 |
| Semaglutide | $99/mo | $279/mo all-inclusive |
| Tirzepatide | $149/mo | Not offered — compounded semaglutide only |
| Coverage | All 50 states | IL, IN, MI, NY, PA |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Injection only | Injection only |
CoreAge Rx
Ranked #1 · Grade A
What we like
- Flat monthly price that stays put through titration — no dose-scaling surprise on your busiest month
- Both compounded semaglutide and tirzepatide on one plan, so you're not re-signing to switch
- Async, no-video intake and all-50-states coverage — start it during a lunch break
The caveats
- Not the rock-bottom sticker price — a couple of teaser tiers elsewhere start lower
- Compounded only — no FDA-approved brand option
- General metabolic program, not a boutique concierge service
LIV by WellNow
Ranked #125 · Grade C
What we like
- A genuinely flat, all-inclusive $279/mo — medication, supplies and unlimited virtual visits, 'no hidden fees — ever,' per its own copy
- Honest, good-faith on-site disclosure that compounded semaglutide is not FDA-approved — unusually direct language for this market
- Backed by an established urgent-care brand (WellNow) rather than an anonymous startup
The caveats
- Compounded semaglutide only — no tirzepatide offered at all, unlike most of this board
- Coverage is limited to five states (IL, IN, MI, NY, PA), tied to WellNow's own regional urgent-care footprint
- No insurance accepted — cash-pay only
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Rx-Readiness Score. Pricing, states and verification reflect each provider's public disclosures at last review; the Rx-Readiness Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.
More head-to-heads
Keep comparing CoreAge Rx and LIV by WellNow against other providers on our shortlist.
Or browse the full comparison hub.